Depression in patients with cardiac disease: A practical review

Journal of Psychosomatic Research

Volumn 48, Issue 4-5, 2000, Pages 379-391

  Lespérance, François ^a,b,c   Frasure Smith, Nancy ^a,b,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antidepressants; Coronary artery disease; Depression; Diagnosis; Treatment

Indexed keywords

AMFEBUTAMONE; AMIODARONE; ANTIDEPRESSANT AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; DIGOXIN; DILTIAZEM; FELODIPINE; FLUOXETINE; FLUVOXAMINE; LABETALOL; LIDOCAINE; METOPROLOL; NEFAZODONE; NICARDIPINE; NIFEDIPINE; NORTRIPTYLINE; PAROXETINE; PINDOLOL; PROPAFENONE; PROPANOL; QUINIDINE; SERTRALINE; TIMOLOL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; VERAPAMIL;

ASTHENIA; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DROWSINESS; DRUG ANTAGONISM; DRUG EFFICACY; FATIGUE; HEADACHE; HOSPITALIZATION; HUMAN; HYPOTENSION; INSOMNIA; MORTALITY; NAUSEA; PROGNOSIS; QUALITY OF LIFE; REVIEW; SEXUAL DYSFUNCTION; TREMOR; XEROSTOMIA;

CORONARY DISEASE; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; HUMANS; PROGNOSIS; QUALITY OF LIFE; RECURRENCE;

EID: 0343517697     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(99)00102-6     Document Type: Review

References (114)

1. Lespérance F., Frasure-Smith N., Talajic M. Major depression before and after myocardial infarction. its nature and consequences Psychosom Med. 58:1996;99-110.
2. Ladwig K.H., Kieser M., König M., Breithardt G., Borggrefe M. Affective disorders and survival after acute myocardial infarction. results from the post-infarction late potential study Eur Heart J. 12:1991;959-964.
3. Frasure-Smith N., Lespérance F., Talajic M. Depression following myocardial infarction. impact on 6-month survival JAMA. 270:1993;1819-1825.
4. Frasure-Smith N., Lespérance F., Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 91:1995;999-1005.
5. Koenig H.G. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 20:1998;29-43.
6. Carney R.M., Rich M.W., teVelde A., Saini J., Clark K., Jaffe A.S. Major depressive disorder in coronary artery disease. Am J Cardiol. 60:1987;1273-1275.
7. Pérez-Stable E.J., Miranda J., Munoz R.F., Ying Y.-W. Depression in medical outpatients. underrecognition and misdiagnosis Arch Intern Med. 150:1990;1083-1088.
8. Freedland K.E., Lustman P.J., Carney R.M., Hong B.A. Underdiagnosis of depression in patients with coronary artery disease. the role of nonspecific symptoms Int J Psychiatry Med. 22:1992;221-229.
9. Hirschfeld R.M.A., Keller M.B., Panico S., Arons B.S., Barlow D., Davidoff F., Endicott J., Froom J., Goldstein M., Gorman J.M.et al. The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA. 277:1997;333-340.
10. Ahern D.K., Gorkin L., Anderson J.L., Tierney C., Hallstrom A., Ewart C., Capone R.J., Schron E., Kornfeld D., Herd J.A.et al. Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS). Am J Cardiol. 66:1990;59-62.
11. Lespérance F, Frasure-Smith N, Théroux P. Depression and 1-year prognosis in unstable angina. Arch Int Med (in press).
12. Morris P.L.P., Robinson R.G., Andrzejewski P., Samuels J., Price T.R. Association of depression with 10-year poststroke mortality. Am J Psychiatry. 150:1993;124-129.
13. Barefoot J.C., Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation. 93:1996;1976-1980.
14. Aromaa A., Raitasalo R., Reunanen A., Impivaara O., Heliovaara M., Knekt P., Lehtinen V., Joukamaa M., Maatela J. Depression and cardiovascular diseases. Acta Psychiatrica Scand. 377(suppl):1994;77-82.
15. Anda R., Williamson D., Jones D., Macera C., Eaker E., Glassman A., Marks J. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology. 4:1993;285-294.
16. Everson S.A., Roberts R.E., Goldberg D.E., Kaplan G.A. Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med. 158:1998;1133-1138.
17. Wulsin L.R., Vaillant G.E., Wells V.E. A systematic review of the mortality of depression. Psychosom Med. 61:1999;6-17.
18. Glassman A.H., Shapiro P.A. Depression and the course of coronary artery disease. Am J Psychiatry. 155:1998;4-11.
19. Frasure-Smith N., Lespérance F. Role of psycho-social factors in CVD. Evidence Based Cardiovasc Med. 2:1998;64-65.
20. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease. epidemiology, biology and treatment Arch Gen Psychiatry. 55:1998;580-592.
21. Rozanski A., Blumenthal J.A., Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 99:1999;2192-2217.
22. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part 1. N Engl J Med. 326:1992;242-250.
23. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. Part 2. N Engl J Med. 326:1992;310-318.
24. Biegon A., Weizman A., Karp L., Ram A., Tiano S., Wolff M. Serotonin 5-HT2 receptor binding on blood platelets - a peripheral marker for depression? Life Sci. 41:1987;2485-2492.
25. 3H-LSD) in the blood platelets of depressed patients. Life Sci. 44:1989;725-734.
26. Nemeroff C.B., Knight D.L., Franks J., Craighead W.E., Krishnan K.R. Further studies on platelet serotonin transporter binding in depression. Am J Psychiatry. 151:1994;1623-1625.
27. Musselman D.L., Tomer A., Manatunga A.K., Knight B.T., Porter M.R., Kasey S., Marzec U., Karker L.A., Nemeroff C.B. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 153:1996;1313-1317.
28. Laghrissi-Thode F., Finkel M.S., Johnson P.C., Pollock B.G. Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 42:1997;290-295.
29. Roy A., Pickar D., de Jong J., Karoum F., Linnoila M. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. relationship to hypothalamic-pituitary-adrenal axis function in depression Arch Gen Psychiatry. 45:1988;849-857.
30. Veith R.C., Lewis N., Linares O.A., Barnes R.F., Raskind M.A., Villacres E.C., Murburg M.M., Ashleigh E.A., Castillo S., Peskind E.R.et al. Sympathetic nervous system activity in major depression - basal and desipramine-induced alterations in plasma norepinephrine kinetics. Arch Gen Psychiatry. 50:1993;1-12.
31. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation 1990;82(suppl I):I-103-I-113.
32. Meredith I.T., Broughton A., Jennings G.L., Esler M.D. Evidence of selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med. 325:1991;618-624.
33. Tofler G.H., Brezinski D., Schafer A.I., Czeisler C.A., Rutherford J.D., Willich S.N., Gleason R.E., Williams G.H., Muller J.E. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 316:1987;1514-1518.
34. Rouleau J.-L., Packer M., Moyé L., DeChamplain J.R., Bichet D., Klein M., Rouleau J.R., Sussex B., Arnold J.M., Sestier F.et al. Prognostic value of neurohumoral activation in patients with an acute myocardial infarction. effect of captopril J Am Coll Cardiol. 24:1994;583-591.
35. Carney R.M., Freedland K.E., Veith R.C., Cryer P.E., Skala J.A., Lynch T., Jaffe A.S. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol Psychiatry. 45:1999;458-463.
36. Kleiger R.E., Stein P.K., Bosner M.S., Rottman J.N. Time domain measurements of heart rate variability. Cardiol Clin. 10:1992;487-498.
37. Carney R.M., Saunders R.D., Freedland K.E., Stein P., Rich M.W., Jaffe A.S. Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol. 76:1995;562-564.
38. Murray C.J.L., Lopez A.D. Global mortality, disability, and the contribution of risk factors. global burden of disease study Lancet. 349:1997;1436-1442.
39. Broadhead W.E., Blazer D.G., George L.K., Tse C.K. Depression, disability days, and days lost from work in a prospective epidemiology survey. JAMA. 264:1990;2524-2528.
40. Von Korff M., Ormel J., Katon W., Lin E.H.B. Disability and depression among high utilizers of health care. a longitudinal analysis Arch Gen Psychiatry. 49:1992;91-100.
41. Simon G.E., Vonkorff M., Barlow W. Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry. 52:1995;850-856.
42. Carney R.M., Freedland K.E., Eisen S.A., Rich M.W., Jaffe A.S. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 14:1995;88-90.
43. Zisook S., Paulus M., Shuchter S.R., Judd L.L. The many faces of depression following spousal bereavement. J Affect Disord. 45:1997;85-95.
44. Diagnostic and statistical manual of mental disorders. 4th ed:1994;American Psychiatric Association, Washington, DC.
45. Sherbourne C.D., Wells K.B., Hays R.D., Rogers W., Burnam A., Judd L.L. Subthreshold depression and depressive disorder. clinical characteristics of general medical and mental health specialty outpatients Am J Psychiatry. 151:1994;1777-1784.
46. Roy-Byrne P., Katon W., Broadhead E., Lepine J.-P., Richards J., Brantley P.J., Russo J., Zinbarg R., Barlow D., Liebowitz M. Subsyndromal ("mixed") anxiety-depression in primary care. J Gen Intern Med. 9:1994;507-512.
47. Kendler K.S. Toward a scientific psychiatric nosology. Strengths and limitations. Arch Gen Psychiatry. 47:1990;969-973.
48. Cohen-Cole S.A., Brown F.W., McDaniel J.S. Assessment of depression and grief reaction in the medically ill. Stoudemire A., Fogel B.S. Psychiatric care of the medical patient. 1993;53-71 Oxford University Press, London.
49. Fava M., Abraham M., Pava J., Shuster J., Rosenbaum J. Cardiovascular risk factors in depression. the role of anxiety and anger Psychosomatics. 37:1996;31-37.
50. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., Charlson M. Vascular depression' hypothesis. Arch Gen Psychiatry. 54:1997;915-922.
51. Krishnan K.R.R., McDonald W.M. Arteriosclerotic depression. Med Hypotheses. 44:1995;111-115.
52. Meyers B.S., Bruce M.L. The depression-dementia conundrum. integrating clinical and epidemiological perspectives Arch Gen Psychiatry. 55:1998;1082-1083.
53. Frasure-Smith N., Lespérance F. Depression and prognosis in coronary disease. Pashkow F.J., Dafoe W.A. Clinical cardiac rehabilitation. a cardiologist's guide 2nd ed:1999;266-279 Williams & Wilkins, Baltimore, Maryland.
54. Davis B.R., Furberg C., Williams C.B. Survival analysis of adverse effects data in the Beta-Blocker Heart Attack Trial. Clin Pharmacol Ther. 41:1987;611-615.
55. Carney R.M., Rich M.W., teVelde A., Saini J., Clark K., Freedland K.E. Prevalence of major depressive disorder in patients receiving beta-blocker therapy versus other medications. Am J Med. 83:1987;223-226.
56. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 4:1961;561-571.
57. Kessler R.C., Zhao S., Blazer D.G., Swartz M. Prevalence, correlates, and course of minor depression and major depression in the national comorbidity survey. J Affect Disord. 45:1997;19-30.
58. Kendler K.S., Gardner C.O. Boundaries of major depression. an evaluation of DSM-IV criteria Am J Psychiatry. 155:1998;172-177.
59. Klerman G.L., Weissman M.M., Rounsaville B.J.et al. Interpersonal psychotherapy of depression. 1984;Jason Aronson, Northvale, New Jersey.
60. Winokur G. All roads lead to depression. clinically homogeneous, etiologically heterogeneous J Affect Disord. 45:1997;97-108.
61. Keitner G.I., Ryan C.E., Miller I.W., Norman W.H. Recovery and major depression. factors associated with twelve-month outcome Am J Psychiatry. 149:1992;93-99.
62. Feldman E.L., Robbins A., Jaffe A. Selections from current literature. minor depression Fam Pract. 15:1998;275-281.
63. Hance M., Carney R.M., Freedland K.E., Skala J. Depression in patients with coronary heart disease. a 12-month follow-up Gen Hosp Psychiatry. 18:1996;61-65.
64. Maier W., Gänsicke M., Weiffenbach O. The relationship between major and subthreshold variants of unipolar depression. J Affect Disord. 45:1997;41-51.
65. Horwath E., Johnson J., Klerman G.L., Weissman M.M. Depressive symptoms as relative and attributable risk factors for first-onset major depression. Arch Gen Psychiatry. 49:1992;817-823.
66. Keller M.B., Lavori P.W., Mueller T.I., Endicott J., Coryell W., Hirschfeld R.M.A., Shea T. Time to recovery, chronicity, and levels of psychopathology in major depression - a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry. 49:1992;809-816.
67. Lin E.H.B., Katon W.J., Vonkorff M., Russo J.E., Simon G.E., Bush T.M., Rutter C.M., Walker E.A., Ludman E. Relapse of depression in primary care. rate and clinical predictors Arch Fam Med. 7:1998;443-449.
68. Paykel E.S., Ramana R., Cooper Z., Hayhurst H., Kerr J., Barocka A. Residual symptoms after partial remission. an important outcome in depression Psychol Med. 25:1995;1171-1180.
69. Keller M.B., Lavori P.W., Lewis C.E., Klerman G.L. Predictors of relapse in major depressive disorder. JAMA. 250:1983;3299-3304.
70. Solomon D.A., Keller M.B., Leon A.C., Mueller T.I., Shea T., Warshaw M., Maser J.D., Coryell W., Endicott J. Recovery from major depression. a 10-year prospective follow-up across multiple episodes Arch Gen Psychiatry. 54:1997;1001-1006.
71. Kendler K.S., Neale M.C., Kessler R.C., Heath A.C., Eaves L.J. Major depression and generalized anxiety disorder. same genes, (partly) different environments? Arch Gen Psychiatry. 49:1992;716-722.
72. Zung W.W.K., Magruder-Habib K., Velez R., Alling W. The co-morbidity of anxiety and depression in general medical patients. a longitudinal study J Clin Psychiatry. 51(suppl 6):1990;77-80.
73. Liebowitz M.R. Depression with anxiety and atypical depression. J Clin Psychiatry. 54(suppl 2):1993;10-14.
74. Murphy J.M., Olivier D.C., Sobol A.M., Monson R.R., Leighton A.H. Diagnosis and outcome. depression and anxiety in a general population Psychol Med. 16:1986;117-126.
75. Von Korff M., Shapiro S., Burke J.D., Teitlebaum M., Skinner E.A., German P., Turner R.W., Klein L., Burns B. Anxiety and depression in a primary care clinic. comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments Arch Gen Psychiatry. 44:1987;152-156.
76. Corruble E., Ginestet D., Guelfi J.D. Comorbidity of personality disorders and unipolar major depression. a review J Affect Disord. 37:1996;157-170.
77. Penninx B.W.J.H., van Tilburg T., Boeke A.J.P., Deeg D.J.H., Kriegsman D.M.W., van Eijk J.Th.M. Effects of social support and personal coping resources on depressive symptoms. different for various chronic diseases? Health Psychol. 17:1998;551-558.
78. Kessler R.C. The effects of stressful life events on depression. Annu Rev Psychol. 48:1997;191-214.
79. Holahan C.J., Moos R.H., Holahan C.K., Brennan P.L. Social support, coping, and depressive symptoms in a late-middle-aged sample of patients reporting cardiac illness. Health Psychol. 14:1995;152-163.
80. Aneshensel C.S., Stone J.D. Stress and depression. a test of the buffering model of social support Arch Gen Psychiatry. 39:1982;1392-1396.
81. George L.K., Blazer D.G., Hughes D.C., Fowler N. Social support and the outcome of major depression. Br J Psychiatry. 154:1989;478-485.
82. Kendler K.S., Prescott C.A. A population-based twin study of lifetime major depression in men and women. Arch Gen Psychiatry. 56:1999;39-44.
83. Fawcett J., Barkin R.L. Efficacy issues with antidepressants. J Clin Psychiatry. 58(suppl 6):1997;32-39.
84. Cohen-Cole S.A., Kaufman K.G. Major depression in physical illness. diagnosis, prevalence, and antidepressant treatment (a ten year review: 1982-1992) Depression. 1:1993;181-204.
85. Roose S.P., Laghrissi-Thode F., Kennedy J.S., Nelson J.C., Bigger J.T., Pollock B.G., Gaffney A., Narayan M., Finkel M.S., McCafferty J.et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 279:1998;287-291.
86. Roose S.P., Glassman A.H., Attia E., Woodring S., Giardina E.G.V., Bigger J.T. Jr. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry. 155:1998;660-665.
87. Lespérance F., Frasure-Smith N., White M., Rouleau J.L. Treating major depression in congestive heart failure. an open-label trial of Nefazadone Journal of Cardiac Failure. 5(Suppl):1999;61.
88. Shapiro P.A., Lespérance F., Frasure-Smith N., O'Connor C.M., Baker B., Jiang J.W., Dorian P., Harrison W., Glassman A.H. An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHAT Trial). Am Heart J. 137:1999;1100-1106.
89. Guidelines for the diagnosis and pharmacological treatment of depression, revised edition. 1999;CANMAT, Toronto.
90. Elkin I., Shea M.T., Watkins J.T., Imber S.D., Sotsky S.M., Collins J.F., Glass D.R., Pilkonis P.A., Leber W.R., Docherty J.P.et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry. 46:1989;971-982.
91. Thase M.E., Greenhouse J.B., Frank E., Reynolds C.F. III, Pilkonis P.A., Hurley K., Grochocinski V. Treatment of major depression with psychotherapy or psychotherapy-pharmacotherapy combinations. Arch Gen Psychiatry. 54:1997;1009-1015.
92. Evans M.D., Hollon S.D., DeRubeis R.J., Piasecki J.M., Grove W.M., Garvey M.J., Tuason V.B. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch Gen Psychiatry. 49:1992;802-808.
93. Reynolds C.F. III, Frank E., Perel J.M., Imber S.D., Cornes C., Miller M.D., Mazumdar S., Houck P.R., Dew M.A., Stack J.A.et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression. a randomized controlled trial in patients older then 59 years JAMA. 281:1999;39-45.
94. Frank E., Kupfer D.J., Wagner E.F., McEachran A.B., Cornes C. Efficacy of interpersonal psychotherapy as a maintenance treatment of recurrent depression - contributing factors. Arch Gen Psychiatry. 48:1991;1053-1059.
95. Beliles K.E., Stoudemire A. Psychopharmacologic treatment of depression in the medically ill. Psychosomatics. 39(suppl):1998;S2-S19.
96. Glassman A.H., Roose S.P., Bigger J.T. Jr. The safety of tricyclic antidepressants in cardiac patients. risk-benefit reconsidered JAMA. 269:1993;2673-2675.
97. Glassman A.H., Preud'homme X.A. Review of the cardiovascular effects of heterocyclic antidepressants. J Clin Psychiatry. 54(suppl):1993;16-22.
98. Roose S.P., Glassman A.H. Antidepressant choice in the patient with cardiac disease. Lessons from the cardiac arrhythmia suppression trial (CAST) studies J Clin Psychiatry. 55(suppl A):1994;83-89.
99. Morganroth J., Goin J.E. Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. a meta-analysis Circulation. 84:1991;1977-1983.
100. Preskorn S.H., Janicak P.J., Davis J.M., Ayd F.J. Advances in the pharmacotherapy of depressive disorders. Janicak P.G., Davis J.M., Preskorn S.H., Ayd F.J. Principles and practice of psychopharmacotherapy. Update 1. 1995;1-24 Williams & Wilkins, Baltimore, Maryland.
101. Harvey A.T., Preskorn S.H. Cytochrome P450 enzymes. interpretation of their interactions with selective serotonin reuptake inhibitors. Part I J Clin Psychopharmacol. 16:1996;273-285.
102. Richelson E. Pharmacokinetic drug interactions of new antidepressants. a review of the effects on metabolism of other drugs Mayo Clin Proc. 72:1997;835-847.
103. Ketter T.A., Flockhart D.A., Post R.M., Denicoff K., Pazzaglia P.J., Marangell L.B., George M.S., Callahan A.M. The emerging role of cytochrome P450 3A in psychopharmacology. J Clin Psychopharmacol. 15:1995;387-398.
104. Nemeroff C.B., DeVane L., Pollock B.G. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry. 153:1996;311-320.
105. Schulberg H.C., Katon W., Simon G.E., Rush A.J. Treating major depression in primary care practice. an update of the agency for health care policy and research practice guidelines Arch Gen Psychiatry. 55:1998;1121-1127.
106. Hollon S.D., DeRubeis R.J., Evans M.D., Wiemer M.J., Garvey M.J., Grove W.M., Tuason V.B. Cognitive therapy and pharmacotherapy for depression. single and in combination Arch Gen Psychiatry. 49:1992;774-781.
107. Simons A.D., Murphy G.E., Levine J.L., Wetzel R.D. Cognitive therapy and pharmacotherapy for depression. sustained improvement over one year Arch Gen Psychiatry. 43:1986;43-48.
108. Glassman A.H. Cigarette smoking. implications for psychiatric illness Am J Psychiatry. 150:1993;546-553.
109. Glassman A.H., Helzer J.E., Covey L.S., Cottler L.B., Stetner F., Tipp J.E., Johnson J. Smoking, smoking cessation, and major depression. JAMA. 264:1990;1546-1549.
110. Breslau N., Peterson E.L., Schultz L.R., Chilcoat H.D., Andreski P. Major depression and stages of smoking. a longitudinal investigation Arch Gen Psychiatry. 55:1998;161-166.
111. Hurt R.D., Sachs D.P., Glover E.D., Offord K.P., Johnson J.A., Dale L.C., Khayrallah M.A., Schroeder D.R., Glover P.N., Sullivan C.R.et al. A comparison of sustained-release bupropion and placebo for smoking. N Engl J Med. 337:1997;1195-1202.
112. Hall S.M., Reus V.I., Munoz R.F., Sees K.L., Humfleet G., Hartz D.T., Frederick S., Triffleman E. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry. 55:1998;683-690.
113. Berlin I., Said S., Spreux-Varoqiaux O., Launay J.M., Olivares R., Millet V., Lecrubier Y., Puech A.J. A reversible monoamine oxidase A inhibitor (moclobemide) facilities smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Ther. 58:1995;444-452.
114. Glassman A.H. Psychiatry and cigarettes. Arch Gen Psychiatry. 55:1998;692-693.